Yale New Haven Clinical Trials

Pain Scales And Pain Assessment
Pain scales are commonly used in pain assessment to rate the impact of pain on a person. Photo Credit: NIH/Warren Grant Magnusen Clinical Center. Sign Up for our Free Newsletters Thanks, You're in! Living Healthy Health Tip of the Day Chronic Pain. ... Read Article

WELCOME [www.yalecancercenter.org]
WELCOME Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven just returned from the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago earlier this week. Smilow Cancer Hospital at Yale-New Haven is proud to introduce the ... Return Document

Reflecting America’s Patient Population— The Need For ...
Healthlawyers.org 25 Analysis Reflecting America’s Patient Population— The Need for Diversity in Clinical Trials By Katherine L. Kraschel, Associate Counsel, Yale New Haven Health System, New Haven, CT, ... Get Document

Wesley H - Prodprofileblob.blob.core.windows.net
2009-2011: Yale-New Haven Hospital, Department of Neurosurgery. Responsible for recruiting and initiating two clinical trials, Actively participated in the numerous brain tumor clinical trials (20+) of the New York Brain Tumor Center. ... Read Content

Yale-New Haven Hospital Is A 944-bed, Not-for-profit Hospital ...
Of the Office of Clinical Trials Support and Research Nursing in the Center for Cancer Research at the National Cancer Institute in Bethesda, MD. Yale-New Haven Hospital is a 944-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale ... Retrieve Here

Kolltan Pharmaceuticals Provides Update On Clinical Pipeline, Corporate Developments And Near-Term Milestones
NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, Inc., a privately held clinical-stage company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for use in oncology and immunology, today announced corporate developments, progress of the Company’s lead development programs and research pipeline and upcoming milestones ... Read News

Yale University Open Data Access (YODA) Project Procedures To ...
Yale University Open Data Access (YODA) Suite 200, New Haven, CT 06510 1 OVERVIEW These procedures support the YODA Project Data Release Policy and more fully describe the future clinical trials to permit the sharing of de-identified data for broader scientific, ... View This Document

20130924 Clinical Research Committee Charter - Yale ITS
Clinical Research Committee Charter Yale New Haven Health Systems, and Yale Health leadership in advancing Yale’s technology footprint and support in clinical research and practice. OnCore Clinical Trials Management System ... View Full Source

The Newsletter Of Yale-New Haven Hospital
Yale-New Haven Hospital has announced the de- Yale New Haven Health System’s clinical redesign activities. Other YNHH senior leadership changes include: to clinical trials offered through Yale Cancer Center. Upcoming health lectures ... Fetch Document

Arthur Schafer - Wikipedia, The Free Encyclopedia
New Haven: Yale University Press. 2000. “Clinical Trials: A Reply to Critics", New England Journal of Medicine, v. 308, n. 6, 1983. “Kontrolieter klinscher Versuch: Dilemma for Artz und Patient”, Medical Tribune, n. 13, Freitag 21, Jan., 1983. ... Read Article

The Immense Benefits Of Phase I Trials - Cancer.yale.edu
These early clinical trials of new cancer therapies have started coming to Yale: time in 2013 working to get Yale into the clinical trials Cancer Hospital at Yale-New Haven with advanced tumors. ... View This Document

Melanoma Markers And Approach To Personalized Treatment - YouTube
Presentation given by Harriet Kluger, MD, as part of the AIM at Melanoma’s Patient & Caregiver Symposium on September 11, 2014. Dr. Kluger is an Associate Professor of Medicine, Medical Oncology at the Yale School of Medicine in New Haven, CT. ... View Video

The Impact Of Clinical Trials On The Use Of Hormone ...
The Impact of Clinical Trials on the Use of Hormone Replacement Therapy A Population-Based Study Nancy Kim, MD,1,2 Cary Gross, Scholars Program, Yale University School of Medicine, New Haven, CT, USA; 3The Yale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, ... Fetch This Document

Yale Cancer Center Evening Oncology Series: Breast Cancer
Yale Cancer Center Evening Oncology Series: Breast Cancer May 7, 2015 Yale Cancer Center Smilow Cancer Hospital at Yale–New Haven YaleCME CONTINUING MEDICAL EDUCATION. Integrate new findings into clinical practice ... Fetch Document

Evidence-Based Strategies To Improve Glycemic Control
Evidence-Based Strategies to Improve Glycemic Control in Type 2 Diabetes Learning Objectives Clinical Chief, Endocrinology Yale-New Haven Hospital New Haven, clinical trials supported by Johnson & Johnson, Lilly, ... Access Doc

INSIDE YALE MEDICAL GROUP World Class Care
Inside Yale Medical Group: World Class Care. INSIDE YALE MEDICAL GROUP. World Class Care. 6. 7: patients have access to clinical trials that may be Yale-New Haven Hospital; Clinical Program Leader, ... Read Document

Yale Stem Cell Transplant - Castle Connolly
Yale-New Haven Hospital is a 944-bed tertiary referral center, the primary teaching hospital for the New clinical trials are open to patients in need of a transplant–and are available in only a handful of cancer centers in the country. ... Read More

Objective Members Responsibilities - Yale ITS
Objective The Clinical Research Committee guides strategy, professionals to advise the University Technology Initiatives Committee (TIC), YSM, Yale New Haven YNHHS, Yale Health, and Yale ITS The perspectives of clinical practice and research, ... View Document

Smilow Cancer Hospital At Yale-New Haven
Expanding clinical trials and developing a clinical program that will provide Smilow Cancer Hospital at Yale-New Haven, 20 York Street, New Haven, CT 06510-3202 Smilow’s 12 Cancer Programs 1. Brain Tumor Program 2. Breast Cancer Program 3. ... View This Document

Alfred Gilman, Sr. - Wikipedia, The Free Encyclopedia
Alfred Gilman, Sr. Alfred Gilman; Born February 5, 1908 Bridgeport, Connecticut: Died: January 13 New Haven, Connecticut: Fields: Pharmacology: Institutions: Gilman and Goodman conducted trials on mice to research on the compounds' cytotoxic properties for white blood cells. [5] [6] ... Read Article

From Clinical Trials To Commercial Use A Nurse Navigation ...
From Clinical Trials to Commercial Use: A Nurse Navigation Strategy to Promote Early Intervention and Consistent Management of Adverse Reactions in the Outpatient Setting Eileen Dehm, RN, Yale New Haven Hospital Created Date: ... Access Content